# MiraLAX

NDC: 76420-489
Generic name: Polyethylene Glycol 3350
Labeler / Manufacturer: ASCLEMED USA INC.
Product type: HUMAN OTC DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER, FOR SOLUTION
Routes: ORAL
Marketing started: 20070201

FDA application: NDA022015

## Active ingredients

- POLYETHYLENE GLYCOL 3350: 17 g/17g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76420-489"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76420-489
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e652042f-3707-4bf6-831d-d806638b7d85